Uveal melanoma: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

21 May 2024

22 April 2024

21 April 2024

6 January 2024

5 December 2023

8 October 2023

18 August 2023

26 July 2023

12 July 2023

18 June 2023

3 March 2023

14 February 2023

12 February 2023

2 February 2023

29 January 2023

7 December 2022

12 October 2022

11 September 2022

23 August 2022

13 July 2022

2 June 2022

29 March 2022

19 March 2022

18 March 2022

  • curprev 16:4016:40, 18 March 2022Reivaj96 talk contribs 30,108 bytes +1,423 Added sub-section in "Treatment" section to reflect FDA-approval of the immunotherapy tebentafusp (Kimmtrak) for a subset of uveal melanoma patients. Link to clinical trial is provided, as well as reference of published results. Drugs used as comparators in the control group are linked to their respective Wikipedia pages undo Tag: Visual edit

7 March 2022

27 January 2022

26 November 2021

19 November 2021

25 October 2021

23 September 2021

20 January 2021

15 January 2021

14 January 2021

1 January 2021

6 December 2020

6 October 2020

3 September 2020

30 August 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)